Sources Used in Current Review
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. St. Louis: Elsevier Saunders; 2006 pp. 1630-1631.
Clarke, W. and Dufour, D. R., Editors (2006). Contemporary Practice in Clinical Chemistry. AACC Press, Washington, DC; p. 264.
deFilippi C. Natriuretic Peptides for Diagnosing Heart Failure and Beyond: What We Know in 2007. (May 24, 2007) Medscape Today. Available online at http://www.medscape.com/viewarticle/557030 through http://www.medscape.com. Accessed September 2008.
Maher KO et al. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics 2008 Jun; 121:e1484. Available online at http://pediatrics.aappublications.org/cgi/content/full/121/6/e1484?linkType=FULL&journalCode=pediatrics&resid=121/6/e1484 through http://pediatrics.aappublications.org. Accessed September 2008.
Sources Used in Previous Reviews
Interview with Alan H.B. Wu, PhD. Director, Clinical Chemistry, Hartford Hospital, Hartford, CT.
"First Blood Test for Congestive Heart Failure Wins FDA Clearance." Clinical Laboratory Strategies, December 2000, Vol. 5, No. 12, p.1.
Thomas, Clayton L., Editor (1997). Taber’s Cyclopedic Medical Dictionary. F.A. Davis Company, Philadelphia, PA [18th Edition].
Pagana, Kathleen D. & Pagana, Timothy J. (2001). Mosby’s Diagnostic and Laboratory Test Reference 5th Edition: Mosby, Inc., Saint Louis, MO.
Tang, W. (2004 February 27). NACB: Recommendations for the use of Cardiac Biomarkers in Heart Failure. NACB: Recommendations for the use of Cardiac Biomarkers in Heart Failure – Chapter 2 [Draft Guidelines]. Available online at http://www.nacb.org/lmpg/biomark/card_biomarkers_chp2.doc through http://www.nacb.org.
Bay, M. et. al. (2003). NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart ONLINE Heart 2003;89:150-154 [On-line journal]. Available online at http://heart.bmjjournals.com/cgi/content/full/89/2/150 through http://heart.bmjjournals.com.
Diagnostic Products Corporation Acquires Nonexclusive Rights to a Key Cardiac Marker, NT-proBNP, from Roche Diagnostics—Agreement widens access to unique marker for heart failure and allows for better/earlier/improved therapy. (2004 February 11) DPC [On-line press release]. Available online at http://www.dpcweb.com/newsreleases/2004/february/ntprobnp.htm through http://www.dpcweb.com.
Roche Receives FDA Clearance for Elecsys proBNP Assay – First Automated Blood Test to Aid in the Diagnosis of Congestive Heart Failure (2002). Roche Diagnostics [On-line press release]. Available online at http://www.roche-diagnostics.com/press_lounge/press_releases/archive/2002_11_20.html through http://www.roche-diagnostics.com